Skip to main content
. 2003 Jul;56(1):57–67. doi: 10.1046/j.1365-2125.2003.01853.x

Table 2.

Mean pharmacokinetic parameter values of dextromethorphan (DEX) and dextrorphan (DOR) according to the best fit models 9 and 7 (Table 1).*

Treatment groups Total clearance (l h−1) Intrinsic metabolic clearance (l h−1) Non-metabolic clearance (l h−1) V (l) ka(h−1) tlag(h) FH(%) [I]/Ki t1/2[1] (h) t1/2[2] (h) k(DOR) (h−1) [V(DOR)/ F(DOR)](l)
DEX (30 mg) 75 523 3 961 2.6 0.8 20 NA 3.1 17 0.51 3776
(13) (257) (0) (167) (0.9) (0.1) (15) (0.3) (4) (0.21) (1382)
[39–85] [59–910] [585–1292] [0.8–3.9] [0.5–1.2] [9–60] [2.3–3.7] [10–24] [0.21–1.07] [1222–6441]
DEX (60 mg) 78a 788a 3 As above 2.0a 0.6ab 16a NA 3.1 16 As above As above
(12) (528) (0) (0.9) (0.1) (14) (0.3) (4)
[43–88] [73–1536] [0.5–3.4] [0.5–1.0] [6–55] [2.2–3.8] [9–26]
DEX (30 mg) 20c 27c 3 As above 1.1c 0.7 78c 19 3.6c 58c 0.34c As above
  + Quinidine (9) (14) (0) (0.7) (0.3) (10) (2) (0.5) (38) (0.14)
  (50 mg) [3–35] [3–56] [0.3–2.4] [0.3–1.7] [62–97] [13–23] [2.7–5.2] [24–145] [0.11–0.63]
*

The numbers in parentheses indicate SD and those in square brackets are the range for each parameter. For a full description of parameters see Appendix. NA, Not applicable.

a

Significantly different from 30-mg arm (P < 0.02);

b

significantly different from quinidine arm (P < 0.05);

c

significantly different from corresponding parameter value in absence of quinidine (P < 0.001).